Muscle Atrophy Clinical Trials

Find Muscle Atrophy Clinical Trials Near You

Efficacy of Supplementation With Micronized Creatine Monohydrate in the Recovery of Muscle Mass, Muscle Strength and Functional Capacity in Older Adults Operated on for Total Knee Arthroplasty: Randomized Clinical Trial

Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement, Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Double-blind randomized placebo-controlled clinical trial with two parallel arms. The main objective is to evaluate the efficacy and safety of creatine supplementation in older adults who have been operated on for total knee arthroplasty and undergoing a usual rehabilitation program. The intervention will consist of daily creatine monohydrate supplementation for 12 weeks. The intervention will start after surgery with a loading dose of 20g/day for 1 week and then continue with a maintenance dose of 5g/day for 11 weeks. Main outcome mesures included muscle mass, muscle strenght, sarcopenia, frailty, functional capacity and physical performance and will be assessed at baseline, 3 and 6 months follow-up.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 65
Healthy Volunteers: f
View:

• Persons 65 years of age or older who have been operated on for the first time for total knee arthroplasty,

• who are undergoing an outpatient rehabilitation program according to standard clinical practice,

• who sign the informed consent form.

Locations
Other Locations
Spain
Elisabet Palomera
RECRUITING
Mataró
Contact Information
Primary
Jéssica Martínez Rodríguez
jmartinezro@csdm.cat
0034 937417700
Time Frame
Start Date: 2025-06-10
Estimated Completion Date: 2027-10-31
Participants
Target number of participants: 262
Treatments
Experimental: CREATINE
The intervention will consist of daily supplementation with micronized creatine monohydrate for 12 weeks. The intervention will start at the time of hospital discharge with a loading dose of 20g/day for 1 week. Subsequently, a maintenance dose of 5g/day will be continued for 11 weeks.
Placebo_comparator: PLACEBO
The control group will follow the same rehabilitation regimen as the intervention group and will receive a placebo. It will start at the time of hospital discharge with a loading dose of 20g/day for 1 week. Subsequently, a maintenance dose of 5g/day will be continued for 11 weeks.
Related Therapeutic Areas
Sponsors
Leads: Consorci Sanitari del Maresme
Collaborators: Fundació Privada Salut del Consorci Sanitari del Maresme

This content was sourced from clinicaltrials.gov